ExactAntigen

TGFBR2 antibody | antibody review based on formal publications
TGFBR2 antibodies
This is a review about TGFBR2 antibodies, based on 18 published articles using TGFBR2 antibodies in western blot, immunohistochemistry, immunoprecipitation, immunocytochemistry, and other immunological technologies. It is aimed to help ExactAntigen visitors find the most suited TGFBR2 antibody.
R & D Systems    search R & D Systems TGFBR2 products
wbR&D Systems goat anti-human TbetaRII antibody was used in western blot to study the interaction of (TGF)-beta type II-B receptor and type I receptor with TGF-beta2 in human HEK 293 cells. to the paper
blockR&D Systems TGF-beta type II receptor-neutralizing antibody was used in blocking experiments to block the effects of TGF-beta1 on the expression of HSP47 in conjunctival fibroblasts isolated from patients with OCP. to the paper
wbR & D Systems goat polyclonal anti-Tbeta RII antibody was used in western blot to study sorting nexin 6 in COS-1, COS-7, and HepG2 cells. to the paper
Santa Cruz Biotechnology    search Santa Cruz Biotechnology TGFBR2 products
ip, wbSanta Cruz Biotechnology T beta RII antibody was used in western blot and immunoprecipitation to study the role of disintegrin and metalloproteinase ADAM12 in TGF-beta signaling through interaction with the type II receptor. to the paper
wbSanta Cruz Biotechnology anti-TbetaRII antibody (sc-1700) was used in human LNCaP cells and in western blot to study the role of epidermal growth factor in transforming growth factor beta signaling and growth suppression. to the paper
wbSanta Cruz Biotech anti-TGF-β1R antibody was used in western blot to study the involvement of the NF-kappa B/matrix metalloproteinase pathway in cardiac fibrosis of mice lacking guanylyl cyclase/natriuretic peptide receptor A. to the paper
wb rabbit anti TbetaRII antibody (L-21, cytoplasmic) was used in western blot to study the role of TbetaRII in TGF-beta regulation of BGN. to the paper
ihSanta Cruz Biotechnology rabbit polyclonal anti-TßRII antibody C-16 was used in paraffin sections from human breast cancer and in immunohistochemistry to study the role of TGF-ß receptors in breast cancer and their significance as prognostic markers. to the paper
wbSanta Cruz Biotechnology Inc anti-TßRII Ab was used in western blot to study the impaired Smad7-Smurf–mediated negative regulation of TGF-ß signaling in scleroderma fibroblasts. to the paper
ihSanta Cruz Biotechnology polyclonal anti-TGF-βRII antibody C-16 was used in immunohistochemistry to study the effect of interaction between transforming growth factor (TGF) -βs and amyloid-β protein on fibrillogenesis. to the paper
wbSanta Cruz rabbit polyclonal TGF-RII antibody was used in western blot to study the role of cyclooxygenase 2 in protein kinase C beta II-mediated colon carcinogenesis. to the paper
wbSanta Cruz Biotechnology rabbit anti-TGF-BRII antibody (which is specific for TGF- RII p70) was used in human breast tumor cells (MDA-MB-231 cells) and in western blot to study the effect of hyaluronan on the interaction between CD44 and the transforming growth factor beta receptor I in metastatic breast tumor cells. to the paper
ihSanta Cruz Biotechnology rabbit anti-TGF-beta RII was used in immunohistochemistry to localize TGF-beta RII in rat corneal endothelial cells. to the paper
ip, wbSanta Cruz Biotechnology polyclonal anti-TβRII antibody C16 was used in immunoprecipitation and western blot to study the interaction of endoglin with the transforming growth factor-β receptors I and II. to the paper
ih, wbSanta Cruz Biotechnology rabbit polyclonal antibody against TGF-beta receptor II was used in western blot and immunohistochemistry to examine the influence of transforming growth factor (TGF) -ß1 on proximal tubular epithelial cell-cell interaction, with particular emphasis on the regulation of adherens junction complex formation. to the paper
ih, wbSanta Cruz Biotechnology TβRII antibody was used in western blot and immunohistochemistry to demonstrate that alterations in the Smad pathway is responsible for TGF-beta hyperresponsiveness. to the paper
ipSanta Cruz Biotechnology rabbit anti-human TGF-βRII antibody C-16 was used in human T47D and MCF-7 cells and in immunoprecipitation to study a signaling pathway for IGFBP-3 from a cell surface receptor to nuclear transcriptional activity. to the paper
wbSanta Cruz Biotechnology rabbit polyclonal anti-Tbeta RII C16 antibody was used in western blot to study sorting nexin 6 in COS-1, COS-7, and HepG2 cells. to the paper
EXALPHA BIOLOGICALS
ihExalpha Biologicals transforming growth factor beta II receptor (TGF beta IIR) polyclonal antibody was used in immunohistochemistry to characterize hepatoma-derived growth factor. to the paper
Articles Reviewed
1:Azeddine Atfi et al. The disintegrin and metalloproteinase ADAM12 contributes to TGF-beta signaling through interaction with the type II receptor. 2007
2:Kyung Song et al. Novel permissive role of epidermal growth factor in transforming growth factor beta (TGF-beta) signaling and growth suppression. Mediation by stabilization of TGF-beta receptor type II. 2006
3:Hendrik Ungefroren et al. Transforming growth factor-beta (TGF-beta) type I receptor/ALK5-dependent activation of the GADD45beta gene mediates the induction of biglycan expression by TGF-beta. 2005
4:Elangovan Vellaichamy et al. Involvement of the NF-kappa B/matrix metalloproteinase pathway in cardiac fibrosis of mice lacking guanylyl cyclase/natriuretic peptide receptor A. 2005
5:Yoshihide Asano et al. Impaired Smad7-Smurf-mediated negative regulation of TGF-beta signaling in scleroderma fibroblasts. 2004
6:Elisabetta del Re et al. In the absence of type III receptor, the transforming growth factor (TGF)-beta type II-B receptor requires the type I receptor to bind TGF-beta2. 2004
7:Allen D Everett et al. Hepatoma-derived growth factor is a pulmonary endothelial cell-expressed angiogenic factor. 2004
8:Miriam B Buck et al. Prognostic significance of transforming growth factor beta receptor II in estrogen receptor-negative breast cancer patients. 2004
9:Darrell D Mousseau et al. A direct interaction between transforming growth factor (TGF)-betas and amyloid-beta protein affects fibrillogenesis in a TGF-beta receptor-independent manner. 2003
10:Mohammed S Razzaque et al. Role of collagen-binding heat shock protein 47 and transforming growth factor-beta1 in conjunctival scarring in ocular cicatricial pemphigoid. 2003
11:Wangsheng Yu et al. Role of cyclooxygenase 2 in protein kinase C beta II-mediated colon carcinogenesis. 2003
12:Ya Chung Tian et al. Interaction between the transforming growth factor-beta type II receptor/Smad pathway and beta-catenin during transforming growth factor-beta1-mediated adherens junction disassembly. 2002
13:Chunming Dong et al. Deficient Smad7 expression: a putative molecular defect in scleroderma. 2002
14:Mercedes Guerrero-Esteo et al. Extracellular and cytoplasmic domains of endoglin interact with the transforming growth factor-beta receptors I and II. 2002
15:Susan Fanayan et al. Signaling through the Smad pathway by insulin-like growth factor-binding protein-3 in breast cancer cells. Relationship to transforming growth factor-beta 1 signaling. 2002
16:Lilly Y W Bourguignon et al. Hyaluronan promotes signaling interaction between CD44 and the transforming growth factor beta receptor I in metastatic breast tumor cells. 2002
17:Nancy C Joyce et al. Mechanisms of mitotic inhibition in corneal endothelium: contact inhibition and TGF-beta2. 2002
18:W T Parks et al. Sorting nexin 6, a novel SNX, interacts with the transforming growth factor-beta family of receptor serine-threonine kinases. 2001


2008©ExactAntigen home | browse | about